Blood pressure measurement in SPRINT (Systolic Blood Pressure Intervention Trial)

Hypertension

Volumn 71, Issue 5, 2018, Pages 848-857

  Johnson, Karen C ^a   Whelton, Paul K ^b   Cushman, William C ^a,c   Cutler, Jeffrey A ^d   Evans, Gregory W ^e   Snyder, Joni K ^d   Ambrosius, Walter T ^e   Beddhu, Srinivasan ^f   Cheung, Alfred K ^g   Fine, Lawrence J ^d   Lewis, Cora E ^h   Rahman, Mahboob ^j   Reboussin, David M ^e   Rocco, Michael V ^d   Oparil, Suzanne ⁱ   Wright, Jackson T ^k  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b TULANE UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f Division of Nephrology and Hypertension and Medical Service   (United States)

^g Division of Nephrology and Hypertension   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ Division of Cardiovascular Diseases   (United States)

^j UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^k UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

more..

Author keywords

blood pressure; cardiovascular diseases; hazard ratio; hypertension; risk

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; BRADYCARDIA; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELECTROLYTE DISTURBANCE; FAINTNESS; FEMALE; FOLLOW UP; FRAMINGHAM RISK SCORE; HISPANIC; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE; AGE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; COMPARATIVE STUDY; CONFIDENCE INTERVAL; HYPERTENSION; MORTALITY; MULTICENTER STUDY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTOR; STANDARDS; SURVIVAL ANALYSIS;

ANTIHYPERTENSIVE AGENT;

AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CONFIDENCE INTERVALS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; SURVIVAL ANALYSIS;

EID: 85048690314     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.117.10479     Document Type: Article

References (33)

1. Mozaffarian D, Benjamin EJ, Go AS, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 2016;133:447-454. doi: 10.1161/CIR.0b013e3182456d46
2. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441-450. doi: 10.1161/CIRCULATIONAHA.115.018912
3. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011- 2012. NCHS Data Brief 2013;133:1-8
4. Miura K, Daviglus ML, Dyer AR, Liu K, Garside DB, Stamler J, Greenland P. Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry. Arch Intern Med. 2001;161:1501-1508
5. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903-1913
6. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 125 million people. Lancet. 2014;383:1899-1911. doi: 10.1016/S0140-6736(14)60685-1
7. Wright JT, Williamson JD, Whelton PK, et al; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103-2116. doi: 10.1056/NEJMoa1511939
8. Thomopoulos C, Parati G, Zanchetti A. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. J Hypertens. 2016;34:613-622. doi: 10.1097/HJH.0000000000000881
9. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665
10. Turnbull F, Neal B, Ninomiya T, Algert C, Arima H, Barzi F, Bulpitt C, Chalmers J, Fagard R, Gleason A, Heritier S, Li N, Perkovic V, Woodward M, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: metaanalysis of randomised trials. BMJ. 2008;336:1121-1123. doi: 10.1136/ bmj.39548.738368.BE
11. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ; Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Hypertension. 2005;45:142-161. doi: 10.1161/01.HYP.0000150859.47929.8e
12. Borhani NO, Applegate WB, Cutler JA, Davis BR, Furberg CD, Lakatos E, Page L, Perry HM, Smith WM, Probstfield JL. Systolic Hypertension in the Elderly Program (SHEP). Part 1: rationale and design. Hypertension. 1991;17:II2-II15
13. Probstfield JL, Applegate WB, Borhani NO, Curb JD, Cutler JA, Davis BR, Furberg CD, Hawkins CM, Lakatos E, Page LB. The Systolic Hypertension in the Elderly Program (SHEP): an intervention trial on isolated systolic hypertension. SHEP Cooperative Research Group. Clin Exp Hypertens A. 1989;11:973-989
14. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697-716. doi: 10.1161/01. CIR.0000154900.76284.F6
15. Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD; ACCORD Study Group. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol. 2007;99(12A):21i- 33i. doi: 10.1016/j.amjcard.2007.03.003
16. Ambrosius WT, Sink KM, Foy CG, et al; SPRINT Study Research Group. The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT). Clin Trials. 2014;11:532-546. doi: 10.1177/1740774514537404
17. Cushman WC, Grimm RH Jr, Cutler JA, Evans GW, Capes S, Corson MA, Sadler LS, Alderman MH, Peterson K, Bertoni A, Basile JN; ACCORD Study Group. Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99(12A):44i-55i. doi: 10.1016/j. amjcard.2007.03.005
18. Beckett NS, Peters R, Fletcher AE, et al; HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898. doi: 10.1056/NEJMoa0801369
19. Kjeldsen SE, Hedner T, Jamerson K, Julius S, Haley WE, Zabalgoitia M, Butt AR, Rahman SN, Hansson L. Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension. 1998;31:1014-1020
20. Messerli FH, Bangalore S, Kjeldsen SE. Letter by Messerli et al regarding article, "The implications of blood pressure measurement methods on treatment targets for blood pressure". Circulation. 2017;135:e45-e46. doi: 10.1161/CIRCULATIONAHA.116.025301
21. Bakris G. Response by Bakris to letter regarding article, "the implications of blood pressure measurement methods on treatment targets for blood pressure". Circulation. 2017;135:e47. doi: 10.1161/ CIRCULATIONAHA.116.026534
22. Kjeldsen SE, Lund-Johansen P, Nilsson PM, Mancia G. Unattended blood pressure measurements in the systolic blood pressure intervention trial: implications for entry and achieved blood pressure values compared with other trials. Hypertension. 2016;67:808-812. doi: 10.1161/ HYPERTENSIONAHA.116.07257
23. Schiffrin EL, Calhoun DA, Flack JM. SPRINT proves that lower is better for nondiabetic high-risk patients, but at a price. Am J Hypertens. 2016;29:2-4. doi: 10.1093/ajh/hpv190
24. SPRINT Protocol. https://www.sprinttrial.org/public/dspScience.cfm. Accessed August 24, 2017
25. SPRINT Manual of Operations - Blood Pressure Measurement. https:// www.sprinttrial.org/public/dspHome.cfm. Accessed August 24, 2017
26. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507-520. doi: 10.1001/jama.2013.284427
27. Mancia G, Fagard R, Narkiewicz K, et al; Task Force Members. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013;31:1281-1357. doi: 10.1097/01. hjh.0000431740.32696.cc
28. Leung AA, Nerenberg K, Daskalopoulou SS, et al; CHEP Guidelines Task Force. Hypertension Canada's 2016 Canadian Hypertension Education Program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol 2016;32:569-588. doi: 10.1016/j.cjca.2016.02.066
29. National Heart, Lung, and Blood Institute. Action to Control Cardiovascular Risk in Diabetes (ACCORD) Manual of Procedures. https://biolincc.nhlbi. nih.gov/studies/accord/. Accessed October 12, 2017
30. Drawz PE, Pajewski NM, Bates JT, et al. Effect of intensive versus standard clinic-based hypertension management on ambulatory blood pressure: results from the SPRINT (Systolic Blood Pressure Intervention Trial) ambulatory blood pressure study. Hypertension. 2017;69:42-50. doi: 10.1161/HYPERTENSIONAHA.116.08076
31. Myers MG. A short history of automated office blood pressure - 15 years to SPRINT. J Clin Hypertens (Greenwich). 2016;18:721-724. doi: 10.1111/jch.12820
32. Graves JW, Nash C, Burger K, Bailey K, Sheps SG. Clinical decision- making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens. 2003;17:823-827. doi: 10.1038/ sj.jhh.1001626
33. Filipovský J, Seidlerová J, Kratochvíl Z, Karnosová P, Hronová M, Mayer O Jr. Automated compared to manual office blood pressure and to home blood pressure in hypertensive patients. Blood Press. 2016;25:228-234. doi: 10.3109/08037051.2015.1134086.